B · Normal
[The concepts of innovative drugs and CRO fluctuated and fell, and Hongbo Pharmaceuticals fell by more than 10%] On October 23, the concepts of innovative drugs and CRO fluctuated and fell, with Hongbo Pharmaceuticals and Biopsis falling by more than 10%, Pluto Pharmaceuticals hitting the limit, Laimei Pharmaceuticals, Nearshore Protein, Jiankai Technology, and Yaokang Biotech leading the decline. On the news, Moderna, a popular U.S. biopharmaceutical stock, closed down more than 17% overnight and once fell more than 26% during the session.
Live broadcast 🕐 2026-10-23 09:58
#Live broadcast #Innovative drugs
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Shanghai Index fell more than 2%, Science and Technology 50 fell more than 3%] 10-23 10:13 [In the first half hour of the opening, the volume of the two markets exceeded 7 10-23 10:01 [Memory chip concept is active, Dagang shares are at daily limit] On October 23, 10-23 09:50 [The concept of humanoid robots has repeatedly strengthened, Zhaowei Electromech 10-23 09:47 [PCB concept collective adjustment, Osconn is approaching the limit] On October 10-23 09:43 [Infrastructure sector fluctuated and pulled up, Nanfang Road Machinery and Beix 10-23 09:40

Comments

0/500
Captcha (click to refresh)
No comments yet